77 related articles for article (PubMed ID: 27035558)
1. Role of estrogen receptor in breast cancer cell gene expression.
Zheng Y; Shao X; Huang Y; Shi L; Chen B; Wang X; Yang H; Chen Z; Zhang X
Mol Med Rep; 2016 May; 13(5):4046-50. PubMed ID: 27035558
[TBL] [Abstract][Full Text] [Related]
2. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
3. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
4. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.
Clocchiatti A; Di Giorgio E; Ingrao S; Meyer-Almes FJ; Tripodo C; Brancolini C
FASEB J; 2013 Mar; 27(3):942-54. PubMed ID: 23159930
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
Liu Z; Lu Y; He Z; Chen L; Lu Y
Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
[TBL] [Abstract][Full Text] [Related]
6. Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer.
Yang J; Wei X; Tufan T; Kuscu C; Unlu H; Farooq S; Demirtas E; Paschal BM; Adli M
Genome Biol; 2018 Nov; 19(1):190. PubMed ID: 30404658
[TBL] [Abstract][Full Text] [Related]
7. Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Bahreini A; Levine K; Santana-Santos L; Benos PV; Wang P; Andersen C; Oesterreich S; Lee AV
Genome Med; 2016 Dec; 8(1):128. PubMed ID: 27964748
[TBL] [Abstract][Full Text] [Related]
8. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
9. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
Ferguson AT; Lapidus RG; Baylin SB; Davidson NE
Cancer Res; 1995 Jun; 55(11):2279-83. PubMed ID: 7538900
[TBL] [Abstract][Full Text] [Related]
10. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
12. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Martini PG; Katzenellenbogen BS
Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
[TBL] [Abstract][Full Text] [Related]
13. Partial least squares based analysis of pathways in recurrent breast cancer.
Gao QG; Li ZM; Wu KQ
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2159-65. PubMed ID: 23893181
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor gene methylation in human breast tumors.
Falette NS; Fuqua SA; Chamness GC; Cheah MS; Greene GL; McGuire WL
Cancer Res; 1990 Jul; 50(13):3974-8. PubMed ID: 2354445
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS
Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation.
Lazennec G; Alcorn JL; Katzenellenbogen BS
Mol Endocrinol; 1999 Jun; 13(6):969-80. PubMed ID: 10379895
[TBL] [Abstract][Full Text] [Related]
18. Partial least squares based gene expression analysis in estrogen receptor positive and negative breast tumors.
Ma W; Zhang TF; Lu P; Lu SH
Eur Rev Med Pharmacol Sci; 2014; 18(2):212-6. PubMed ID: 24488910
[TBL] [Abstract][Full Text] [Related]
19. GREB 1 is a critical regulator of hormone dependent breast cancer growth.
Rae JM; Johnson MD; Scheys JO; Cordero KE; Larios JM; Lippman ME
Breast Cancer Res Treat; 2005 Jul; 92(2):141-9. PubMed ID: 15986123
[TBL] [Abstract][Full Text] [Related]
20. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
